Cogprints

Complications and Mortality of Single Versus Dual Chamber Implantable Cardioverter Defibrillators

Bagherzadeh, Ataallah and Emkanjoo, Zahra and Haghjoo, Majid and Farahani, Maryam Moshkani and Alizadeh, Abolfath and Sadr-Ameli, Mohammad Ali (2006) Complications and Mortality of Single Versus Dual Chamber Implantable Cardioverter Defibrillators. [Journal (Paginated)]

Full text available as:

[img]HTML
34Kb
[img]
Preview
PDF
374Kb

Abstract

Background: The implantable cardioverter defibrillators (ICDs) are increasingly being used as a treatment modality for life threatening tachyarrhythmia. The purpose of this study was to compare the frequency of complications and mortality between single-chamber and dual-chamber ICD implantation in Shahid Rajaie cardiovascular center. Methods and results: Between January 2000 and December 2004, 234 patients received ICD by a percutaneous transvenous approach and were followed for 33 ± 23 months. The cumulative incidence of complications was 9.4% over the follow-up period. There was no significant difference in overall complication rate between single chamber (VR) and dual chamber (DR) ICD groups in the follow-up period (P= 0.11). The risk of complications did not have any statistically significant difference in secondary versus primary prevention groups (P=0.06). The complications were not associated with the severity of left ventricular systolic dysfunction (P=0.16).The frequency of lead-related complications was higher in dual chamber ICDs in comparison with single chamber ICDs (P=0.02). There was no significant difference in mortality between different sex groups (P=0.37), different indications for ICD implantation (P=0.43) or between VR and DR ICD groups (P= 0.55). Predictors of mortality were NYHA class III or more (P<0.001), age >65 years (P=0.011) and LVEF<30% (P<0.001). The mortality in patients with CAD and DCM were significantly higher than those with other structural heart diseases (P=0.001). Conclusions: Close monitoring of patients during the first 2 month after ICD implantation is recommended because the majority of complications occur early after the procedure.

Item Type:Journal (Paginated)
Keywords:implantable cardioverter-defibrillator; complication; mortality
Subjects:JOURNALS > Indian Pacing and Electrophysiology Journal
ID Code:4800
Deposited By:Indian Pacing and Electrophysiology, Journal
Deposited On:01 Apr 2006
Last Modified:11 Mar 2011 08:56

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1. Zipes DP, Roberts D. The Pacemaker Cardioverter Defibrillator Investigators. Results of the international study of the implantable pacemaker cardioverter defibrillator: a comparison of epicardial and endocardial lead systems. Circulation 1995; 92:59-65.

2. Stambler BS, Wood MA, Damiano RJ. Sensing/pacing lead complications with a newer generation implantable cardioverter defibrillator: World wide experience the Guardian ATP 4210 clinical trial. J AM Coll Cardiol; 23:123-32.

3. Bardy GH, Johnson G, Poole JE, et al. A simplified, single lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993; 88: 543-547.

4. Bardy GH, Yee R, Jung W. for the active can investigators. Multicenter experience with a pectoral unipolar implantable cardioverter defibrillator. J Am Coll Cardiol 1996; 28: 400-410.

5. The Antiarrhythmic Versus Implantable Defibrillator (AVID) investigators. A comparison of anti arrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Eng J Med 1997; 337:1576-1583.

6. Gradatus R, Block M, Brachmann J , et al. Mortality, Morbidity and complications in 3334 patients with implantable cardioverter- defibrillators. PACE 2003; 26: 1511-1518.

7. Kron J, Herre J, Renfroe EG, et al. Lead and device-related complications in the Antiarrhythmics Versus Implantable Defibrillators Trial. Am Heart J 2001; 141:92-8.

8. Connolly SJ, Gent M, Roberts RS, et al., for the CIDS investigators. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of implantable cardioverter defibrillator against Amiodarone. Circulation 2000; 101:1297-1302.

9. Gold MR, Peters RW, Johnson JW, et al. Complications associated with pectoral implantation of Cardioverter Defibrillators. PACE 1997; 20: 208-211.

10. Witte J, Bondke HJ. The incidence of pacemaker pocket complications depending on pulse generator size and shape- conclusion for defibrillator therapy. PACE 1995; 18:1793.

11. Grimm W, Menz N, Hoffmann J. Complications of third generation implantable cardioverter defibrillator therapy. PACE 1999; 22: 206-11.

12. Rosenqvist M, Beyer T, Block M, European 7219 Jewel ICD investigators. Adverse events with transvenous implantable cardioverter- defibrillators: a prospective multicenter study. Circulation 1998; 98:663-70.

13. Nunain SO, Roelke M; Trouton T. Limitations and late complications of third generation automatic cardioverter- defibrillators. Circulation 1995; 19: 2204-13.

14. Pacifico A, Wheelan KR, Nasir N Jr. Long term follow-up of cardioverter defibrillator implanted under conscious sedation in prepectoral subfacial position. Circulation 1997; 95: 946-950.

15. Brooks R, Garan H, Torchiana D. Three-year outcome of a non-thoracotomy approach to cardioverter defibrillator implantation in 189 consecutive patients. Am J Cardiol 1994; 74: 1011-5.

16. Strickberger SA, Hummel JD, Daoud E. Implantation by electrophysiologists of 100 consecutive cardioverter Defibrillators with nonthoracotomy lead systems. Circulation 1994; 90:868-72.

17. Schwartzman D, Nallamothu N, Callans DJ. Postoperative lead-related complications in patients with nonthoracotomy defibrillation systems. Am J Cardiol 1995; 26:776-86.

18. Kuch KH, Cappata R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102:748-754.

19. Noseworthy PA, Lashevsky I, Dorian P, et al. Feasibility of implantatable Cardioverter Defibrillator use in elderly patients. PACE 2004; 24:373-378.

20. Gupta S, Prevel CD, Shaheen K, et al. Wound complication s and treatment of the infected implantable Cardioverter Defibrillator generator. J Card Surg 1993; 8:671-7.

21. Wunderly RG, Maloney J, Edel T, et al. Infections in implantable Cardioverter Defibrillator patients. PACE 1990; 13: 1360-4.

22. Hauser RG, Kurschinski DT, Mcveigh K, et al. Clinical results with nonthoracotomy ICD systems. PACE 1993; 16: 141-148.

23. Byrd CL. Clinical experience with the extrathoracic introducer insertion technique. PACE 1993; 16:1781-4.

24. Parsonnet V, Roelke M. The cephalic vein cut down versus subclavian puncture for pacemaker/ICD lead implantation. PACE 1999; 22:695-7.

25. Kettering K, Mewis C, Dornberger V, et al. Long term experience with subclavian ICD leads: A comparison among three different types of subclavian leads. PACE 2004; 27: 1355-1361.

26. Glikson M, Lipchenca I, Viskin S, et al. Long term outcome of patients who received implantable cardioverter-defibrillators for stable ventricular tachycardia. J Cardiovasc Electrophysiol, 2004; 15: 658-664.

Metadata

Repository Staff Only: item control page